These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 9444451

  • 1. Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker.
    Okano GJ, Rascati KL, Wilson JP, Remund DD, Grabenstein JD, Brixner DI.
    Clin Ther; 1997; 19(6):1433-45; discussion 1424-5. PubMed ID: 9444451
    [Abstract] [Full Text] [Related]

  • 2. Cost containment for treating hypertension in African Americans: impact of a combined ACE inhibitor-calcium channel blocker.
    Kountz DS.
    J Natl Med Assoc; 1997 Jul; 89(7):457-60. PubMed ID: 9220694
    [Abstract] [Full Text] [Related]

  • 3. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.
    Dickson M, Plauschinat CA.
    Am J Cardiovasc Drugs; 2008 Jul; 8(1):45-50. PubMed ID: 18303937
    [Abstract] [Full Text] [Related]

  • 4. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.
    Yokoyama K, Yang W, Preblick R, Frech-Tamas F.
    J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390
    [Abstract] [Full Text] [Related]

  • 5. Changes in the phamacologic treatment of hypertension in the Department of Veterans Affairs 1997-1999: decreased use of calcium antagonists and increased use of beta-blockers and thiazide diuretics.
    Siegel D, Lopez J, Meier J, Cunningham F.
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):957-62. PubMed ID: 11587164
    [Abstract] [Full Text] [Related]

  • 6. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting.
    Sapienza S, Sacco P, Floyd K, DiCesare J, Doan QD.
    Clin Ther; 2003 Jun; 25(6):1872-87. PubMed ID: 12860503
    [Abstract] [Full Text] [Related]

  • 7. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy.
    Taylor AA, Shoheiber O.
    Congest Heart Fail; 2003 Jun; 9(6):324-32. PubMed ID: 14688505
    [Abstract] [Full Text] [Related]

  • 8. [One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].
    Simonyi G, Ferenci T, Finta E, Igaz I, Balogh S, Gasparics R, Medvegy M.
    Orv Hetil; 2019 Mar; 160(9):343-348. PubMed ID: 30798621
    [Abstract] [Full Text] [Related]

  • 9. Costs of current antihypertensive therapy in Switzerland: an economic evaluation of 3,489 patients in primary care.
    Schäfer HH, Scheunert U.
    Swiss Med Wkly; 2013 Mar; 143():w13854. PubMed ID: 24163048
    [Abstract] [Full Text] [Related]

  • 10. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.
    Mazzaglia G, Mantovani LG, Sturkenboom MC, Filippi A, Trifirò G, Cricelli C, Brignoli O, Caputi AP.
    J Hypertens; 2005 Nov; 23(11):2093-100. PubMed ID: 16208153
    [Abstract] [Full Text] [Related]

  • 11. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.
    Siegel D, Lopez J.
    JAMA; 1997 Dec 03; 278(21):1745-8. PubMed ID: 9388150
    [Abstract] [Full Text] [Related]

  • 12. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
    Hilleman DE, Mohiuddin SM, Lucas BD, Stading JA, Stoysich AM, Ryschon K.
    Clin Ther; 1994 Dec 03; 16(1):88-102; discussion 87. PubMed ID: 7911403
    [Abstract] [Full Text] [Related]

  • 13. Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad.
    Tomas A, Tomić Z, Milijasević B, Ban M, Horvat O, Vukmirović S, Sabo A.
    Vojnosanit Pregl; 2016 Jun 03; 73(6):531-7. PubMed ID: 27498444
    [Abstract] [Full Text] [Related]

  • 14. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr 03; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 15. [Antihypertensive pharmacotherapy of patients in primary care with either a statutory or private health insurance].
    Laux G, Szecsenyi J, Miksch A, Grün B, Gutscher A, Grün B, Rosemann T, Kühlein T.
    Med Klin (Munich); 2009 Feb 15; 104(2):108-13. PubMed ID: 19242661
    [Abstract] [Full Text] [Related]

  • 16. Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension.
    Tardif JC, Ducharme A, Yu H, Wogen J, Guertin MC.
    Clin Ther; 2004 Jul 15; 26(7):1073-83. PubMed ID: 15336472
    [Abstract] [Full Text] [Related]

  • 17. Prescribing pattern of antihypertensive drugs by family physicians and general practitioners in the primary care setting in Bahrain.
    Sequeira RP, Jassim KA, Damanhori AH, Mathur VS.
    J Eval Clin Pract; 2002 Nov 15; 8(4):407-14. PubMed ID: 12421390
    [Abstract] [Full Text] [Related]

  • 18. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M, Kravzov-Jinich J, Guadarrama-Atrizco MD, Rubio-Poo C, Wertheimer AI.
    Res Social Adm Pharm; 2006 Mar 15; 2(1):22-37. PubMed ID: 17138499
    [Abstract] [Full Text] [Related]

  • 19. The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus.
    Burke TA, Sturkenboom MC, Ohman-Strickland PA, Wentworth CE, Rhoads GG.
    Pharmacoepidemiol Drug Saf; 2007 Sep 15; 16(9):979-87. PubMed ID: 17605137
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.